DMII
Drugs Made In America Acquisition II Corp. Ordinary SharesFinancial Services·Shell Companies
$10.06
$528M market cap
Revenue
$0.0M
Free Cash Flow
$-0.1M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
2-Year Price History
$10.06+1.8%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.0 | -0.1 | -0.1 | 4.3 | -0.1 | -0.1 | -0.0 | 0.4 | 0.0 | 50.0 | -- | -- | -- |
Valuation & Metrics
Market Stats
Price$10.06
Market Cap$528M
Enterprise Value$528M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield0.0%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.0M
Net Income$4.3M
Free Cash Flow$-0.1M
Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC--
WC Change % Rev0.0%
Interest Coverage--
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares0.0M
Days to Cover1.0
Change (vs Prior)+0.0%
Need at least 2 settlement dates for chart
Cash Runway
40.7months
WATCH
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
82.9%(+18.0% YoY)
66 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
0.1%(+0.0% YoY)
1 filers
Vanguard, iShares, SPDR
Market makers
0.1%(+0.0% YoY)
1 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| Magnetar Financial LLC | $26.9M | $9.90 | +$0 | +$26.9M | -0.8% | $9.54B |
| MMCAP International Inc. SPC | $26.9M | $9.97 | +$26.9M | +$26.9M | -3.5% | $1.16B |
| Karpus Management, Inc. | $25.9M | $9.94 | +$14.5M | +$25.9M | -0.3% | $3.07B |
| GLAZER CAPITAL, LLC | $23.4M | $9.90 | −$1K | +$23.4M | +8.8% | $4.51B |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $20.0M | $9.97 | +$19.9M | +$20.0M | -0.2% | $60.08B |
| MILLENNIUM MANAGEMENT LLC | $19.7M | $9.92 | +$4.7M | +$19.7M | -0.5% | $127.40B |
| Hudson Bay Capital Management LP | $19.7M | $9.90 | +$0 | +$19.7M | +1.9% | $15.12B |
| WOLVERINE ASSET MANAGEMENT LLC | $17.9M | $9.93 | +$7.3M | +$17.9M | +1.9% | $2.32B |
| Polar Asset Management Partners Inc. | $15.0M | $9.90 | +$0 | +$15.0M | +1.8% | $3.16B |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $15.0M | $9.90 | +$0 | +$15.0M | +5.6% | $1.50B |
| D. E. Shaw & Co., Inc. | $13.9M | $9.92 | +$3.9M | +$13.9M | -0.3% | $118.02B |
| HGC Investment Management Inc. | $12.3M | $9.90 | +$0 | +$12.3M | -4.0% | $451M |
| AQR Arbitrage LLC | $11.1M | $9.90 | −$389K | +$11.1M | -0.0% | $5.11B |
| ARISTEIA CAPITAL LLC | $11.0M | $9.90 | +$0 | +$11.0M | +5.0% | $2.68B |
| Vivaldi Asset Management, LLC | $10.6M | $9.90 | −$10.0M | +$10.6M | +3.3% | $1.90B |
| OMERS ADMINISTRATION Corp | $10.0M | $9.90 | +$0 | +$10.0M | -0.2% | $15.55B |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | $10.0M | $9.90 | +$0 | +$10.0M | +0.9% | $2.68B |
| TWO SIGMA INVESTMENTS, LP | $8.8M | $9.90 | +$0 | +$8.8M | -0.9% | $117.03B |
| PICTON MAHONEY ASSET MANAGEMENT | $8.7M | $9.90 | +$0 | +$8.7M | +1.4% | $9.44B |
| Ghisallo Capital Management LLC | $7.5M | $9.90 | +$0 | +$7.5M | +1.5% | $2.56B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BEARISH
Holders
+0.96%
avg per quarter
Holders (ex-self)
+0.97%
excl. this stock
Buyers (this Q)
-1.10%
30 buyers · $0.12B in
Sellers (this Q)
+1.55%
15 sellers · $0.02B out
alpha coverage: 99% of $ has a lifetime-alpha record
Holder behavior (holder profile)source: holder
On big dips (−10%+)
-6.8%
how holders react when this stock falls
On quiet Qs
-1.4%
−10% to +10% baseline
On rallies (+10%+)
-13.6%
how they react when this stock rises
Holders' portfolio flow this Q
+5.8%
inflows — adds are organic
Sellers' portfolio flow this Q
+4.9%
Sellers grew AUM elsewhere — opinionated cut of this stock.
Biggest decreases this quarter
New buyers this quarter
Top-5 holders · 28.1%
Magnetar Financial LLC--
MMCAP International Inc. SPC--
Karpus Management, Inc.--
GLAZER CAPITAL, LLC--
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
Magnetar Financial LLC2.7MMMCAP International Inc. SPC2.7MKarpus Management, Inc.2.6MGLAZER CAPITAL, LLC2.3MVivaldi Asset Management, LLC1.1MHEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND2.0MMILLENNIUM MANAGEMENT LLC2.0MHudson Bay Capital Management LP2.0MWOLVERINE ASSET MANAGEMENT LLC1.8MPolar Asset Management Partners Inc.1.5MTENOR CAPITAL MANAGEMENT Co., L.P.1.5M
Related Stocks
Investors who own this also own
Stocks held by the same active managers as this one, ranked by score — how much more often these appear together than random chance (1× = baseline). Excludes index ETFs and market makers; minimum 3 shared holders.
| Ticker | Name | Co-holders | Score |
|---|---|---|---|
| RDAGU | Republic Digital Acquisition Company Unit | 3 | 531.00× |
Corporate
Order Flow (FINRA, ~3w lag)
47.5%retail-5.9pp
5.9%dark+17.7pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.
Filing Risk Analysis
Filing Risk Scores
Drugs Made In America Acquisition II Corp.: Standard SPAC Structure Masking Massive Dilution and Insider Overpayments
Overall Risk
7/10
Fraud
3/10
Dilution
9/10
Insolvency
8/10
Earnings Overstated
1/10
Hidden Liabilities
5/10
Legal
2/10
Audit Warnings
9/10
Hidden Upside
2/10
Contextually Acceptable
7/10